In addition to MEK inhibition, several other molecules germane to the ERK signaling pathway, including RAS [73], B-RAF kinase [74], DUSPs [44,75], tropomyosin receptor kinase (TRK) [76], and FOXO [49], are also being pursued as anti-cancer targets. The gene discussed is MAP2K7; the disease is cancer.